Loading clinical trials...
Loading clinical trials...
A Multi Centre, Single Arm, Observational Study on Safety and Efficacy of MabThera Plus Chemotherapy as 1st Line Treatment in Patients With DLBCL or FL
Conditions
Locations
24
China
The Affiliated Hospital of Military Medical Sciences(The 307th Hospital of Chinese PLA)
Beijing, China
the First Hospital of Jilin University
Changchun, China
Xiangya Hospital of Centre-South University
Changsha, China
Changzhou First People's Hospital
Changzhou, China
Daqing Oilfield General Hospital
Daqing, China
The First People's Hospital of Foshan
Foshan, China
Start Date
January 19, 2011
Primary Completion Date
July 15, 2016
Completion Date
July 15, 2016
Last Updated
November 14, 2017
NCT05139017
NCT01804686
NCT05755087
NCT04739813
NCT06785818
NCT06043011
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions